Company: IXHL
Filing Date: 2025-01-10
Form Type: 8-K
Source: 0001213900-25-002666
Chunk: 0

Company: Incannex Healthcare Inc.
Filing Date: 2025-01-10
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing.

On
January 3, 2025, Incannex Healthcare Inc. (the “ Company”) received a written notice (the “ Notice”) from the Listing
Qualifications Department (the “ Staff”) of The Nasdaq Stock Market LLC (“ Nasdaq”) notifying the Company that
the Company is not in compliance with Nasdaq Listing Rule 5450(b)(2)(A) (the “ Listing Rule”), which requires the Company
to maintain a minimum Market Value of Listed Securities (“ MVLS”) of at least $50.0 million. The Notice is only a notification
of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on the
Nasdaq Global Market.

The
Notice states that the Company has 180 calendar days, or until July 2, 2025, to regain compliance
with the Listing Rule. To regain compliance, the Company’s MVLS must meet or exceed
$50.0 million for a minimum of ten consecutive business days during the 180-day compliance
period ending on July 2, 2025. Alternatively, the Company
may submit an application and pay the related fee to transfer to The Nasdaq Capital Market
(the “ Capital Market”) to take advantage of the Capital Market’s listing
requirements, provided that it then satisfies the applicable requirements for continued listing
on the Capital Market. the the

Forward-Looking
Statements